
Accure Oncology Labs Private Limited
About Accure Oncology Labs Private Limited
Data last updated:
Accure Oncology Labs Private Limited was a private limited company based in New Delhi, Delhi, India, operated as a subsidiary of Accure Labs Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 April 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC176795.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ajay Vikram Singh and Asit Chandra Bose.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Flat No.1406A 14th Floor Building No. 89 Hemkunth Chamber Nehru, Place, New Delhi, Delhi, India – 110019.
Company details
Contact details
Accure Oncology Labs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No.1406A 14th Floor Building No. 89 Hemkunth Chamber Nehru, Place, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Accure Oncology Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Accure Oncology Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Accure Oncology Labs Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Accure Oncology Labs Private Limited, buy the company report.
Board of directors of Accure Oncology Labs Private Limited
Accure Oncology Labs has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Vikram Singh Also directs: Basix Earth Private Limited | Director | 23 Mar 2017 | 9 Years 7 Months | As last reported |
| Asit Chandra Bose | Director | 27 Jul 2016 | 10 Years 3 Months | As last reported |
Auditor
Accure Oncology Labs Private Limited is audited by Vijay Mukesh & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vijay Mukesh & Co. | FY 2017 | 14554N |
Shareholding
The shareholding of Accure Oncology Labs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Accure Oncology Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Accure Oncology Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Accure Oncology Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Accure Oncology Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Accure Oncology Labs Private Limited has 8 board changes on record since 2014: 2 appointments and 6 cessations. The latest: Ajay Vikram Singh ceased to be Additional Director on 29 Sep 2017.
Frequently asked questions
Accure Oncology Labs has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Accure Oncology Labs was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 15 April 2008 and is registered under CIN U24232DL2008PTC176795. The company has been struck off by the Registrar of Companies and is no longer operational.
Accure Oncology Labs had 2 directors:
- Ajay Vikram Singh - Director
- Asit Chandra Bose - Director
The CIN (Corporate Identification Number) of Accure Oncology Labs is U24232DL2008PTC176795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Accure Oncology Labs is at Flat No.1406A 14th Floor Building No. 89 Hemkunth Chamber Nehru, Place, New Delhi, Delhi, India – 110019.
Accure Oncology Labs was incorporated on 15 April 2008. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Accure Oncology Labs on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
Accure Oncology Labs operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Ajay Vikram Singh ceased to be Additional Director on 29 Sep 2017. Brij Sarin ceased to be Director on 30 Mar 2017. Ajay Vikram Singh was appointed as Director on 23 Mar 2017. Accure Oncology Labs has 8 board changes on record in total.
The compliance status of Accure Oncology Labs is compliant as of 02 September 2026.

